Paras Biopharmaceuticals Finland Oy

About Paras Biopharmaceuticals Finland Oy:

Paras Biopharmaceuticals Finland Oy is a Finnish biopharmaceuticals company having niche expertise in producing microbial-based biopharmaceutical products. After its inception in 2012, the company heavily focused on investing in developing microbial technologies for efficient production of microbial biologics. As a result of sustained efforts from the team comprising of protein scientists, bioprocess engineers and technologists and a strong experience in developing biologics in a most efficient manner, Paras Biopharma successfully developed these unique technologies having role in enabling and enhancing the production of intricate recombinant proteins. Paras Biopharma technologies have been successfully used for production of difficult-to-express proteins such as nanobodies, peptibodies, antibody fragments, long peptides, fusion proteins etc.

Company activities & offerings are categorized in 3 major areas:

1. End-to-end services for Contract Development & Microbial Biologics Manufacturing (CDMO).

2. Development of Recombinant expression systems and process technologies for biologics and biosimilars.

3. Development and offering of Recombinant Bioprocess Enzymes.